By Elric Langton | 17 November 2022
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a clinical-stage infectious disease pharmaceutical company with a unique capital light clinical model, announces that it will be holding a Capital Markets Day for analysts and institutional investors on Wednesday 30 November between 10am - 12:45pm.
Poolbeg has entered a very excβ¦